Showing results (221-230 of 527) with videos related to

Sort By:
Pageof 53
The Annals of Thoracic Surgery|November 4, 2020
Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air SpacesAtsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, et al.
Thoracic Cancer|December 20, 2022
Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumoniaAtsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, et al.
General Thoracic and Cardiovascular Surgery|April 23, 2017
Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancersKeizo Misumi, Hiroaki Harada, Norifumi Tsubokawa, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 2, 2014
Surgical outcomes of non-small-cell lung carcinoma in patients previously treated for gastric cancerNorifumi Tsubokawa, Takahiro Mimae, Keiju Aokage, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 3, 2015
Histologic changes associated with the use of fibrinogen- and thrombin-impregnated collagen in the prevention of pulmonary air leakageNorifumi Tsubokawa, Yoshihiro Miyata, Takahiro Mimae, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 11, 2022
Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non-small cell lung cancerKazuya Takamochi, Kenji Suzuki, Masahiro Tsuboi, et al.
Thoracic Cancer|February 2, 2022
Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case reportNao Kitasaki, Yoichi Hamai, Toru Yoshikawa, et al.
In Vivo (Athens, Greece)|October 29, 2022
Prognostic Factors for Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by SurgeryNao Kitasaki, Yoichi Hamai, Manabu Emi, et al.
Cancers|October 26, 2024
Relationship of Immune-Related Adverse Events with Tumor Response and Prognosis in Esophageal Squamous Cell Carcinoma Following Nivolumab MonotherapyYoichi Hamai, Yuta Ibuki, Tomoaki Kurokawa, et al.
Cancer|February 7, 2007
Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesotheliomaTakeshi Mimura, Akihiko Ito, Toshiko Sakuma, et al.
Pageof 53